Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO30021 | Rheum emodi | Species | Polygonaceae | Eukaryota | Roots | Gorkha district, Nepal | 1996-OCT |
PMID[12932135] |
NPO28914 | Caragana sinica | Species | Fabaceae | Eukaryota |
PMID[22209460] |
|||
NPO20312 | Pterocarpus marsupium | Species | Fabaceae | Eukaryota | heartwood | DOI[10.1021/np50031a029] | ||
NPO28914 | Caragana sinica | Species | Fabaceae | Eukaryota | TM-MC* | |||
NPO12759 | Rheum australe | Species | Polygonaceae | Eukaryota | TCMID* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 20 | % | 9214733 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 64 | % | 9214733 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 33 | % | 9214733 |
NPT1 | Others | Radical scavenging activity | IC50 | = | 4.7 | ug/ml | 12932135 | |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 350.6 | mg/dl | 8377021 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 19.05 | mg/dl | 8377021 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 32 | mg/dl | 8377021 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 292.8 | mg/dl | 8377021 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 41.1 | mg/dl | 8377021 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Ratio | = | 0.09 | 8377021 | |
NPT1 | Others | Radical scavenging activity | IC50 | > | 200000 | nM | 22209460 | |
NPT2 | Others | Unspecified | IC50 | > | 200000 | nM | 22209460 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC71210 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9783 | High Similarity | NPC310128 |
0.9712 | High Similarity | NPC471520 |
0.9429 | High Similarity | NPC230285 |
0.9429 | High Similarity | NPC59951 |
0.9429 | High Similarity | NPC103342 |
0.9429 | High Similarity | NPC103904 |
0.9429 | High Similarity | NPC184536 |
0.9429 | High Similarity | NPC146679 |
0.9366 | High Similarity | NPC470216 |
0.9362 | High Similarity | NPC136840 |
0.9362 | High Similarity | NPC262094 |
0.9362 | High Similarity | NPC90582 |
0.9357 | High Similarity | NPC152042 |
0.9357 | High Similarity | NPC143799 |
0.9357 | High Similarity | NPC241838 |
0.9353 | High Similarity | NPC254841 |
0.9291 | High Similarity | NPC281207 |
0.9291 | High Similarity | NPC269652 |
0.9236 | High Similarity | NPC178343 |
0.9236 | High Similarity | NPC5820 |
0.9236 | High Similarity | NPC306488 |
0.9231 | High Similarity | NPC158874 |
0.9184 | High Similarity | NPC318424 |
0.9178 | High Similarity | NPC477941 |
0.9167 | High Similarity | NPC273538 |
0.9167 | High Similarity | NPC216538 |
0.9161 | High Similarity | NPC266725 |
0.9161 | High Similarity | NPC200694 |
0.9161 | High Similarity | NPC473042 |
0.9149 | High Similarity | NPC124269 |
0.9149 | High Similarity | NPC276905 |
0.9143 | High Similarity | NPC473887 |
0.9143 | High Similarity | NPC194281 |
0.9143 | High Similarity | NPC234133 |
0.9143 | High Similarity | NPC231772 |
0.9143 | High Similarity | NPC216361 |
0.9143 | High Similarity | NPC127447 |
0.9143 | High Similarity | NPC116775 |
0.9143 | High Similarity | NPC256042 |
0.9143 | High Similarity | NPC187432 |
0.9143 | High Similarity | NPC281917 |
0.9143 | High Similarity | NPC47815 |
0.9143 | High Similarity | NPC29353 |
0.9143 | High Similarity | NPC124784 |
0.9133 | High Similarity | NPC210048 |
0.9133 | High Similarity | NPC161650 |
0.9103 | High Similarity | NPC124729 |
0.9103 | High Similarity | NPC153758 |
0.9103 | High Similarity | NPC470458 |
0.9097 | High Similarity | NPC24821 |
0.9097 | High Similarity | NPC302181 |
0.9097 | High Similarity | NPC9117 |
0.9097 | High Similarity | NPC293053 |
0.9097 | High Similarity | NPC212932 |
0.9097 | High Similarity | NPC190637 |
0.9085 | High Similarity | NPC274784 |
0.9085 | High Similarity | NPC310135 |
0.9085 | High Similarity | NPC20709 |
0.9085 | High Similarity | NPC265871 |
0.9085 | High Similarity | NPC222342 |
0.9085 | High Similarity | NPC78913 |
0.9085 | High Similarity | NPC150648 |
0.9085 | High Similarity | NPC329203 |
0.9085 | High Similarity | NPC18260 |
0.9085 | High Similarity | NPC225153 |
0.9078 | High Similarity | NPC250266 |
0.9078 | High Similarity | NPC299379 |
0.9078 | High Similarity | NPC266597 |
0.9078 | High Similarity | NPC188879 |
0.9073 | High Similarity | NPC264932 |
0.9073 | High Similarity | NPC311574 |
0.9065 | High Similarity | NPC82225 |
0.9065 | High Similarity | NPC18877 |
0.9065 | High Similarity | NPC20560 |
0.9065 | High Similarity | NPC204960 |
0.9065 | High Similarity | NPC144051 |
0.9065 | High Similarity | NPC294593 |
0.9065 | High Similarity | NPC159623 |
0.9065 | High Similarity | NPC28753 |
0.9054 | High Similarity | NPC295650 |
0.9048 | High Similarity | NPC470461 |
0.9041 | High Similarity | NPC476182 |
0.9041 | High Similarity | NPC122828 |
0.9041 | High Similarity | NPC211466 |
0.9041 | High Similarity | NPC176869 |
0.9041 | High Similarity | NPC44721 |
0.9041 | High Similarity | NPC40086 |
0.9041 | High Similarity | NPC3779 |
0.9041 | High Similarity | NPC472918 |
0.9034 | High Similarity | NPC326500 |
0.9034 | High Similarity | NPC230943 |
0.9028 | High Similarity | NPC53192 |
0.9021 | High Similarity | NPC110228 |
0.9021 | High Similarity | NPC159275 |
0.9021 | High Similarity | NPC129853 |
0.9021 | High Similarity | NPC188243 |
0.9021 | High Similarity | NPC6407 |
0.9021 | High Similarity | NPC241100 |
0.9021 | High Similarity | NPC76445 |
0.9021 | High Similarity | NPC284550 |
0.9014 | High Similarity | NPC118813 |
0.9014 | High Similarity | NPC201395 |
0.9014 | High Similarity | NPC99333 |
0.9014 | High Similarity | NPC280284 |
0.9014 | High Similarity | NPC188947 |
0.9013 | High Similarity | NPC269906 |
0.9013 | High Similarity | NPC306978 |
0.9013 | High Similarity | NPC172687 |
0.9007 | High Similarity | NPC288084 |
0.9007 | High Similarity | NPC13408 |
0.9007 | High Similarity | NPC240593 |
0.9007 | High Similarity | NPC72452 |
0.9007 | High Similarity | NPC240147 |
0.9007 | High Similarity | NPC61546 |
0.9007 | High Similarity | NPC121243 |
0.9 | High Similarity | NPC248872 |
0.9 | High Similarity | NPC286336 |
0.8993 | High Similarity | NPC129132 |
0.8993 | High Similarity | NPC257756 |
0.8993 | High Similarity | NPC212631 |
0.8993 | High Similarity | NPC205468 |
0.8993 | High Similarity | NPC87231 |
0.898 | High Similarity | NPC168085 |
0.898 | High Similarity | NPC244407 |
0.898 | High Similarity | NPC296869 |
0.898 | High Similarity | NPC470460 |
0.8973 | High Similarity | NPC229190 |
0.8966 | High Similarity | NPC113770 |
0.8958 | High Similarity | NPC324386 |
0.8958 | High Similarity | NPC110969 |
0.8958 | High Similarity | NPC213322 |
0.8958 | High Similarity | NPC3188 |
0.8958 | High Similarity | NPC4743 |
0.8958 | High Similarity | NPC282300 |
0.8958 | High Similarity | NPC312391 |
0.8951 | High Similarity | NPC303633 |
0.8951 | High Similarity | NPC96565 |
0.8951 | High Similarity | NPC216978 |
0.8951 | High Similarity | NPC261234 |
0.8951 | High Similarity | NPC55018 |
0.8951 | High Similarity | NPC301217 |
0.8951 | High Similarity | NPC140890 |
0.8951 | High Similarity | NPC220062 |
0.8951 | High Similarity | NPC230902 |
0.8951 | High Similarity | NPC217186 |
0.8951 | High Similarity | NPC53181 |
0.8944 | High Similarity | NPC295261 |
0.8944 | High Similarity | NPC287246 |
0.8944 | High Similarity | NPC107586 |
0.8944 | High Similarity | NPC290291 |
0.8944 | High Similarity | NPC296490 |
0.8944 | High Similarity | NPC275055 |
0.8944 | High Similarity | NPC32441 |
0.8944 | High Similarity | NPC228661 |
0.8944 | High Similarity | NPC243083 |
0.8944 | High Similarity | NPC12296 |
0.8944 | High Similarity | NPC79943 |
0.8944 | High Similarity | NPC13768 |
0.894 | High Similarity | NPC476652 |
0.894 | High Similarity | NPC211482 |
0.8936 | High Similarity | NPC239495 |
0.8936 | High Similarity | NPC9985 |
0.8936 | High Similarity | NPC13575 |
0.8929 | High Similarity | NPC139813 |
0.8929 | High Similarity | NPC337373 |
0.8929 | High Similarity | NPC175098 |
0.8929 | High Similarity | NPC188646 |
0.8929 | High Similarity | NPC274121 |
0.8929 | High Similarity | NPC242294 |
0.8929 | High Similarity | NPC50898 |
0.8929 | High Similarity | NPC213216 |
0.8929 | High Similarity | NPC56031 |
0.8929 | High Similarity | NPC192304 |
0.8929 | High Similarity | NPC312318 |
0.8929 | High Similarity | NPC263670 |
0.8929 | High Similarity | NPC78540 |
0.8929 | High Similarity | NPC472365 |
0.8921 | High Similarity | NPC475589 |
0.8921 | High Similarity | NPC186097 |
0.8921 | High Similarity | NPC473584 |
0.8921 | High Similarity | NPC308037 |
0.8921 | High Similarity | NPC64359 |
0.8921 | High Similarity | NPC262359 |
0.8921 | High Similarity | NPC313618 |
0.8921 | High Similarity | NPC475009 |
0.8921 | High Similarity | NPC475008 |
0.8921 | High Similarity | NPC31872 |
0.8919 | High Similarity | NPC37226 |
0.8919 | High Similarity | NPC226644 |
0.8919 | High Similarity | NPC317492 |
0.8919 | High Similarity | NPC277032 |
0.8912 | High Similarity | NPC17816 |
0.8912 | High Similarity | NPC12148 |
0.8912 | High Similarity | NPC166757 |
0.8912 | High Similarity | NPC130581 |
0.8912 | High Similarity | NPC259632 |
0.8912 | High Similarity | NPC14001 |
0.8904 | High Similarity | NPC49130 |
0.8904 | High Similarity | NPC208176 |
0.8904 | High Similarity | NPC279417 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC71210 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9167 | High Similarity | NPD4378 | Clinical (unspecified phase) |
0.8944 | High Similarity | NPD1550 | Clinical (unspecified phase) |
0.8944 | High Similarity | NPD1552 | Clinical (unspecified phase) |
0.8921 | High Similarity | NPD1240 | Approved |
0.8881 | High Similarity | NPD1549 | Phase 2 |
0.8836 | High Similarity | NPD6799 | Approved |
0.8794 | High Similarity | NPD1607 | Approved |
0.8693 | High Similarity | NPD3882 | Suspended |
0.8671 | High Similarity | NPD1510 | Phase 2 |
0.8636 | High Similarity | NPD7075 | Discontinued |
0.8609 | High Similarity | NPD6599 | Discontinued |
0.8591 | High Similarity | NPD1512 | Approved |
0.8562 | High Similarity | NPD7096 | Clinical (unspecified phase) |
0.8523 | High Similarity | NPD7410 | Clinical (unspecified phase) |
0.8516 | High Similarity | NPD4381 | Clinical (unspecified phase) |
0.85 | High Similarity | NPD7804 | Clinical (unspecified phase) |
0.8497 | Intermediate Similarity | NPD6801 | Discontinued |
0.8497 | Intermediate Similarity | NPD1934 | Approved |
0.8483 | Intermediate Similarity | NPD2796 | Approved |
0.8456 | Intermediate Similarity | NPD1511 | Approved |
0.8442 | Intermediate Similarity | NPD2393 | Clinical (unspecified phase) |
0.8435 | Intermediate Similarity | NPD2800 | Approved |
0.8431 | Intermediate Similarity | NPD7411 | Suspended |
0.8387 | Intermediate Similarity | NPD3817 | Phase 2 |
0.8323 | Intermediate Similarity | NPD3818 | Discontinued |
0.8323 | Intermediate Similarity | NPD2801 | Approved |
0.8282 | Intermediate Similarity | NPD6797 | Phase 2 |
0.828 | Intermediate Similarity | NPD3749 | Approved |
0.8269 | Intermediate Similarity | NPD8443 | Clinical (unspecified phase) |
0.8255 | Intermediate Similarity | NPD3750 | Approved |
0.8252 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.8247 | Intermediate Similarity | NPD4380 | Phase 2 |
0.8243 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.8232 | Intermediate Similarity | NPD7251 | Discontinued |
0.8231 | Intermediate Similarity | NPD1551 | Phase 2 |
0.8205 | Intermediate Similarity | NPD7819 | Suspended |
0.8199 | Intermediate Similarity | NPD6168 | Clinical (unspecified phase) |
0.8199 | Intermediate Similarity | NPD6167 | Clinical (unspecified phase) |
0.8199 | Intermediate Similarity | NPD6166 | Phase 2 |
0.8188 | Intermediate Similarity | NPD1243 | Approved |
0.8182 | Intermediate Similarity | NPD7808 | Phase 3 |
0.8176 | Intermediate Similarity | NPD2344 | Approved |
0.817 | Intermediate Similarity | NPD5403 | Approved |
0.817 | Intermediate Similarity | NPD920 | Approved |
0.8158 | Intermediate Similarity | NPD5401 | Approved |
0.8133 | Intermediate Similarity | NPD1878 | Clinical (unspecified phase) |
0.811 | Intermediate Similarity | NPD7074 | Phase 3 |
0.8072 | Intermediate Similarity | NPD4338 | Clinical (unspecified phase) |
0.8067 | Intermediate Similarity | NPD7421 | Clinical (unspecified phase) |
0.8049 | Intermediate Similarity | NPD7054 | Approved |
0.8039 | Intermediate Similarity | NPD2533 | Approved |
0.8039 | Intermediate Similarity | NPD2534 | Approved |
0.8039 | Intermediate Similarity | NPD642 | Clinical (unspecified phase) |
0.8039 | Intermediate Similarity | NPD2532 | Approved |
0.8028 | Intermediate Similarity | NPD1203 | Approved |
0.8026 | Intermediate Similarity | NPD643 | Clinical (unspecified phase) |
0.8012 | Intermediate Similarity | NPD6559 | Discontinued |
0.8 | Intermediate Similarity | NPD919 | Approved |
0.8 | Intermediate Similarity | NPD7472 | Approved |
0.7987 | Intermediate Similarity | NPD2935 | Discontinued |
0.7987 | Intermediate Similarity | NPD7768 | Phase 2 |
0.7975 | Intermediate Similarity | NPD7852 | Clinical (unspecified phase) |
0.7961 | Intermediate Similarity | NPD2309 | Approved |
0.7925 | Intermediate Similarity | NPD5402 | Approved |
0.7919 | Intermediate Similarity | NPD3748 | Approved |
0.7905 | Intermediate Similarity | NPD6651 | Approved |
0.7901 | Intermediate Similarity | NPD6959 | Discontinued |
0.7901 | Intermediate Similarity | NPD1247 | Approved |
0.784 | Intermediate Similarity | NPD5494 | Approved |
0.7831 | Intermediate Similarity | NPD7286 | Phase 2 |
0.7817 | Intermediate Similarity | NPD9717 | Approved |
0.7805 | Intermediate Similarity | NPD3926 | Phase 2 |
0.78 | Intermediate Similarity | NPD2799 | Discontinued |
0.7764 | Intermediate Similarity | NPD4868 | Clinical (unspecified phase) |
0.7755 | Intermediate Similarity | NPD2313 | Discontinued |
0.7751 | Intermediate Similarity | NPD4419 | Clinical (unspecified phase) |
0.7746 | Intermediate Similarity | NPD422 | Phase 1 |
0.7744 | Intermediate Similarity | NPD6232 | Discontinued |
0.774 | Intermediate Similarity | NPD6832 | Phase 2 |
0.7738 | Intermediate Similarity | NPD5953 | Discontinued |
0.7724 | Intermediate Similarity | NPD2798 | Approved |
0.7712 | Intermediate Similarity | NPD2654 | Approved |
0.7711 | Intermediate Similarity | NPD7473 | Discontinued |
0.7707 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.7682 | Intermediate Similarity | NPD7033 | Discontinued |
0.7662 | Intermediate Similarity | NPD4628 | Phase 3 |
0.7651 | Intermediate Similarity | NPD943 | Approved |
0.7635 | Intermediate Similarity | NPD3268 | Approved |
0.7622 | Intermediate Similarity | NPD1547 | Clinical (unspecified phase) |
0.761 | Intermediate Similarity | NPD3226 | Approved |
0.76 | Intermediate Similarity | NPD1933 | Approved |
0.759 | Intermediate Similarity | NPD7184 | Clinical (unspecified phase) |
0.7589 | Intermediate Similarity | NPD1548 | Phase 1 |
0.7582 | Intermediate Similarity | NPD1471 | Phase 3 |
0.756 | Intermediate Similarity | NPD3751 | Discontinued |
0.7545 | Intermediate Similarity | NPD2403 | Approved |
0.7534 | Intermediate Similarity | NPD2797 | Approved |
0.7529 | Intermediate Similarity | NPD7993 | Clinical (unspecified phase) |
0.7517 | Intermediate Similarity | NPD6798 | Discontinued |
0.7516 | Intermediate Similarity | NPD6099 | Approved |
0.7516 | Intermediate Similarity | NPD6100 | Approved |
0.7516 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD1610 | Phase 2 |
0.75 | Intermediate Similarity | NPD2354 | Approved |
0.75 | Intermediate Similarity | NPD4908 | Phase 1 |
0.7483 | Intermediate Similarity | NPD6355 | Discontinued |
0.7483 | Intermediate Similarity | NPD1899 | Clinical (unspecified phase) |
0.7468 | Intermediate Similarity | NPD2346 | Discontinued |
0.7466 | Intermediate Similarity | NPD3225 | Approved |
0.7465 | Intermediate Similarity | NPD9545 | Approved |
0.7451 | Intermediate Similarity | NPD4308 | Phase 3 |
0.7451 | Intermediate Similarity | NPD1509 | Clinical (unspecified phase) |
0.7448 | Intermediate Similarity | NPD1608 | Approved |
0.7447 | Intermediate Similarity | NPD9493 | Approved |
0.743 | Intermediate Similarity | NPD8090 | Clinical (unspecified phase) |
0.7425 | Intermediate Similarity | NPD3787 | Discontinued |
0.7425 | Intermediate Similarity | NPD5711 | Approved |
0.7425 | Intermediate Similarity | NPD5710 | Approved |
0.7423 | Intermediate Similarity | NPD1465 | Phase 2 |
0.7415 | Intermediate Similarity | NPD3266 | Approved |
0.7415 | Intermediate Similarity | NPD3267 | Approved |
0.7412 | Intermediate Similarity | NPD5844 | Phase 1 |
0.7401 | Intermediate Similarity | NPD7879 | Clinical (unspecified phase) |
0.74 | Intermediate Similarity | NPD1296 | Phase 2 |
0.74 | Intermediate Similarity | NPD3764 | Approved |
0.74 | Intermediate Similarity | NPD4907 | Clinical (unspecified phase) |
0.7378 | Intermediate Similarity | NPD2296 | Approved |
0.7368 | Intermediate Similarity | NPD447 | Suspended |
0.7368 | Intermediate Similarity | NPD1729 | Discontinued |
0.7368 | Intermediate Similarity | NPD230 | Phase 1 |
0.7365 | Intermediate Similarity | NPD1019 | Discontinued |
0.7365 | Intermediate Similarity | NPD7199 | Phase 2 |
0.7355 | Intermediate Similarity | NPD2355 | Clinical (unspecified phase) |
0.7355 | Intermediate Similarity | NPD2343 | Clinical (unspecified phase) |
0.7355 | Intermediate Similarity | NPD2353 | Approved |
0.7351 | Intermediate Similarity | NPD6233 | Phase 2 |
0.7338 | Intermediate Similarity | NPD651 | Clinical (unspecified phase) |
0.7329 | Intermediate Similarity | NPD1481 | Phase 2 |
0.7329 | Intermediate Similarity | NPD3972 | Approved |
0.7325 | Intermediate Similarity | NPD6398 | Clinical (unspecified phase) |
0.7301 | Intermediate Similarity | NPD7615 | Clinical (unspecified phase) |
0.7296 | Intermediate Similarity | NPD7390 | Discontinued |
0.7288 | Intermediate Similarity | NPD4287 | Approved |
0.7285 | Intermediate Similarity | NPD411 | Approved |
0.7278 | Intermediate Similarity | NPD3887 | Approved |
0.7278 | Intermediate Similarity | NPD4361 | Phase 2 |
0.7278 | Intermediate Similarity | NPD4362 | Clinical (unspecified phase) |
0.7273 | Intermediate Similarity | NPD4288 | Approved |
0.7267 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.726 | Intermediate Similarity | NPD1535 | Discovery |
0.725 | Intermediate Similarity | NPD7004 | Clinical (unspecified phase) |
0.7241 | Intermediate Similarity | NPD17 | Approved |
0.7235 | Intermediate Similarity | NPD7784 | Clinical (unspecified phase) |
0.7234 | Intermediate Similarity | NPD1241 | Discontinued |
0.7222 | Intermediate Similarity | NPD4360 | Phase 2 |
0.7222 | Intermediate Similarity | NPD4363 | Phase 3 |
0.7219 | Intermediate Similarity | NPD7229 | Phase 3 |
0.7205 | Intermediate Similarity | NPD5049 | Phase 3 |
0.72 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.719 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.719 | Intermediate Similarity | NPD1613 | Approved |
0.719 | Intermediate Similarity | NPD4307 | Phase 2 |
0.7178 | Intermediate Similarity | NPD7458 | Discontinued |
0.7175 | Intermediate Similarity | NPD8434 | Phase 2 |
0.7152 | Intermediate Similarity | NPD37 | Approved |
0.7143 | Intermediate Similarity | NPD5124 | Phase 1 |
0.7143 | Intermediate Similarity | NPD5123 | Clinical (unspecified phase) |
0.7143 | Intermediate Similarity | NPD6234 | Discontinued |
0.7126 | Intermediate Similarity | NPD4965 | Approved |
0.7126 | Intermediate Similarity | NPD4967 | Phase 2 |
0.7126 | Intermediate Similarity | NPD4966 | Approved |
0.7124 | Intermediate Similarity | NPD4062 | Phase 3 |
0.7119 | Intermediate Similarity | NPD8055 | Clinical (unspecified phase) |
0.7114 | Intermediate Similarity | NPD1876 | Approved |
0.7103 | Intermediate Similarity | NPD1894 | Discontinued |
0.7086 | Intermediate Similarity | NPD6104 | Discontinued |
0.7078 | Intermediate Similarity | NPD4060 | Phase 1 |
0.7074 | Intermediate Similarity | NPD7584 | Approved |
0.7067 | Intermediate Similarity | NPD1164 | Approved |
0.7052 | Intermediate Similarity | NPD7893 | Clinical (unspecified phase) |
0.7048 | Intermediate Similarity | NPD6280 | Approved |
0.7048 | Intermediate Similarity | NPD6279 | Approved |
0.7039 | Intermediate Similarity | NPD1008 | Clinical (unspecified phase) |
0.7027 | Intermediate Similarity | NPD6782 | Approved |
0.7027 | Intermediate Similarity | NPD6781 | Approved |
0.7027 | Intermediate Similarity | NPD6780 | Approved |
0.7027 | Intermediate Similarity | NPD6778 | Approved |
0.7027 | Intermediate Similarity | NPD6777 | Approved |
0.7027 | Intermediate Similarity | NPD6779 | Approved |
0.7027 | Intermediate Similarity | NPD1201 | Approved |
0.7027 | Intermediate Similarity | NPD6776 | Approved |
0.7025 | Intermediate Similarity | NPD6006 | Clinical (unspecified phase) |
0.7025 | Intermediate Similarity | NPD6005 | Phase 3 |
0.7025 | Intermediate Similarity | NPD6004 | Phase 3 |
0.7025 | Intermediate Similarity | NPD6002 | Phase 3 |
0.7025 | Intermediate Similarity | NPD6003 | Clinical (unspecified phase) |
0.7018 | Intermediate Similarity | NPD6808 | Phase 2 |
0.7006 | Intermediate Similarity | NPD8313 | Approved |
0.7006 | Intermediate Similarity | NPD8312 | Approved |
0.7005 | Intermediate Similarity | NPD7435 | Discontinued |
PubChem CID   | 134369 |
ChEMBL   | CHEMBL512396 |
ZINC   |
Molecular Weight:   | 302.08 |
ALogP:   | -1.7682 |
MLogP:   | 2.56 |
XLogP:   | 1.226 |
# Rotatable Bonds:   | 7 |
Polar Surface Area:   | 96.22 |
# H-Bond Aceptor:   | 2 |
# H-Bond Donor:   | 3 |
# Rings:   | 3 |
# Heavy Atoms:   | 22 |